Definitive Treatment in Transition: De-Escalation, Biomarkers and Immunotherapy in Head and Neck Radiation Oncology
Immunotherapy has transformed the care of patients with recurrent/metastatic head and neck cancer but integration into definitive management has been more challenging.
Category
  • Head and Neck
  • Immunotherapy
Format
  • onDemand
  • Webinars
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $0.00